Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Hemab Therapeutics Hldgs (COAG): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
6 analysts
Options Flow (P/C)
—
Avg Consensus PT
$52
+74.2%
Highest Price Target
$64
+113.8%
Lowest Price Target
$36
+20.2%
Short Interest
—
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | Rodman & Renshaw | Michael G. King Jr.— | +87.0% | $56 | Initiate | Buy |
| Aug 12, 2026 | Wedbush | David Nierengarten— | +113.8% | $55 → $64 | Maintained | Outperform |